Answers are grounded in this paper and cite their sources.
Fear-related disorders—including post-traumatic stress disorder (PTSD), specific phobias, and generalized anxiety disorder—are among the most prevalent and treatment-resistant psychiatric conditions. Despite decades of molecular and cellular advances, systemic pharmacological interventions and approaches targeting isolated brain regions have had limited therapeutic capacity, particularly in refractory patients. This mini-review argues that the translational impasse stems from a reductionist framework that treats mental disorders in general, and fear-related disorders in particular, as a localized phenomenon rather than a distributed network property. We synthesize recent evidence from engram research, oscillatory dynamics, and systems consolidation demonstrating that fear memories are encoded, maintained, and retrieved through brain-wide networks. We outline how emerging technologies such as high-density electrophysiology, calcium imaging, and functional neuroimaging combined with graph-theoretical analysis can map memory networks at scale, enabling precision interventions such as closed-loop neuromodulation and connectivity-based treatment prediction. Adopting a transdiagnostic perspective aligned with the Research Domain Criteria (RDoC), we position persistent aversive memory as a dimensional mechanism that crosses diagnostic boundaries, a perspective we propose as necessary for the development of more effective clinical interventions.
No takes yet. Share an insight, caveat, or question.
Sierra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: